# Neuro3d

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuro3d-s-a

- Industry: Pharmaceuticals
- Headquarters: Mulhouse, France
- Total disclosed funding: $59M
- Latest round: Series C (Jan 3, 2005)
- Investors on record: 8

## About

Founded in 2000 and based in Mulhouse, France, Neuro3d S.A. is a biopharmaceutical company that operates as a manufacturer of medical drugs for the treatment of psychiatric disorders.

## Funding rounds

- Series C, Jan 3, 2005, $32M — Apax Partners, Ardian, Sofinnova Partners, TVM Capital Life Science, Gilde Healthcare, Gimv, Scottish Widows Investment Partnership, HealthCap
- Series B, Sep 25, 2002, $20M — Apax Partners, Sofinnova Partners, TVM Capital Life Science, HealthCap
- Series A, Nov 1, 2000, $7.6M — Apax Partners, Sofinnova Partners

## Investors

- Apax Partners (https://capitalatlas.ai/funds/apax-partners) — Series A, Series B, Series C
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A, Series B, Series C
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series B, Series C
- HealthCap — Series B, Series C
- Ardian (https://capitalatlas.ai/funds/ardian) — Series C
- Gilde Healthcare (https://capitalatlas.ai/funds/gilde-healthcare) — Series C
- Gimv (https://capitalatlas.ai/funds/gimv) — Series C
- Scottish Widows Investment Partnership (https://capitalatlas.ai/funds/scottish-widows-investment-partnership) — Series C